Number of shares and voting rights
Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF - Autorité des Marchés Financiers)
Press release
Avignon, May 14th, 2014
30.04.2014
Total number of outstanding shares forming the capital
- 7,852,055 ordinary shares under ISIN FR0000054694 - 2,534 shares issued from stock-options under ISIN FR0000054694 |
7,854,589 |
Number of shares with double voting rights | 851,442 |
Total number of gross voting rights | 8,706,031 |
Number of shares without voting rights
- 6,476 bearer shares in the frame of the liquidity contract |
- 6,476 |
Total number of exercisable voting rights* | 8,699,555 |
* Real number of voting rights = total number of voting rights - number of shares without voting rights
If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com
-
Financial schedule
- Q1 2014 results:
- 2014 H1 sales
- 2014 first-half results
- 2014 third-quarter sales
- 2014 third-quarter results
- Annual revenue
- Annual results26 May 2014
25 July 2014
29 August 2014
4 November 2014
28 November 2014
3 February 2015
31 March 2015
-
Upcoming events
- AGM 26 June 2014
Naturex has been listed since October 1996 on NYSE Euronext in Paris, Segment B
Total number of shares comprising the share capital: 7,854,589
ISIN FR0000054694 NATUREX is a component of the CAC PEA-PME, CAC Small, Gaïa Index. Naturex is eligible for the "long only" Deferred Settlement Service (SRD). SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY |
About Naturex
Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs more than 1,450 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.
- Contacts
Thierry Lambert
Chair and Chief Executive Officer Tel.: +33 (0)4 90 23 96 89 t.lambert@naturex.com |
Thierry-Bertrand Lambert
Chief Financial Officer Tel.: +33 (0)4 90 23 96 89 t.b.lambert@naturex.com |
Carole Alexandre
Investor Relations Tel.: +33 (0)4 90 23 78 28 c.alexandre@naturex.com |
Anne Catherine Bonjour
Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 acbonjour@actus.fr |
Information relative au nombre total de droits de vote et d'actions composant le capital :
- Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-35946-cp-naturex_140514.pdf
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer